How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration

Journal of Clinical Pharmacy and Therapeutics

Volumn 39, Issue 4, 2014, Pages 390-398

  Guirguis, L M ^a   Makowsky, M J ^a   Hughes, C A ^a   Sadowski, C A ^a   Schindel, T J ^a   Yuksel, N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

pharmacists; prescribing; scope of practice

Indexed keywords

ARTICLE; CANADA; COMMUNITY CARE; FEMALE; HUMAN; LONG TERM CARE; MALE; MASS COMMUNICATION; PATIENT CARE; PHARMACIST; PRESCRIPTION; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; SCOPE OF PRACTICE; TELEPHONE INTERVIEW; HEALTH CARE SURVEY; LAW; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; PHARMACY; PROFESSIONAL STANDARD;

PRESCRIPTION DRUG;

ALBERTA; FEMALE; HEALTH CARE SURVEYS; HUMANS; LEGISLATION, PHARMACY; MALE; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PHARMACISTS; PRESCRIPTION DRUGS; PROFESSIONAL PRACTICE; PROFESSIONAL ROLE;

EID: 84904116245     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12165     Document Type: Article

References (36)

1. Emmerton L, Marriott J, Bessell T, Nissen L, Dean L,. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci, 2005; 8: 217-225.
2. Tonna AP, Stewart D, West B, McCaig D,. Pharmacist prescribing in the UK-a literature review of current practice and research. J Clin Pharm Ther, 2007; 32: 545-556.
3. Hammond RW, Schwartz AH, Campbell MJ, et al,. Collaborative drug therapy management by pharmacists-2003. Pharmacotherapy, 2003; 23: 1210-1225.
4. Secretariat for the Blueprint for Pharmacy National Coordinating Office. Cross-Jurisdictional Scan of Legislative and Policy Framework Ottawa: Canadian Pharmacists Association; 2012. Available at: http://blueprintforpharmacy.ca/ news/news-story/2011/04/19/download-full-legislative-and-policy-framework- report (accessed 9 May 2013).
5. Yuksel N, Eberhart G, Bungard TJ,. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm, 2008; 65: 2126-2132.
6. MacLeod-Glover N,. An explanatory policy analysis of legislative change permitting pharmacists in Alberta, Canada, to prescribe. Int J Pharm Pract, 2011; 19: 70-78.
7. Welcome to Alberta Netcare. Available at: http://www.albertanetcare.ca (accessed 15 April 2013).
8. Alberta Pharmacy Practice Initiative explores pharmacist remuneration. Available at: http://blueprintforpharmacy.ca/news/news-story/2011/04/13/alberta- alberta-pharmacy-practice-initiative-explores-pharmacist-remuneration (accessed 5 March 2013).
9. More health care options for Albertans with expanded role for pharmacists. Available at: http://alberta.ca/NewsFrame.cfm?ReleaseID=/acn/ 201202/3193577D3F312-EBAE-3E34-4AA1D8513857D09F.html (accessed 15 April 2013).
10. Guirguis L, Cooney D, Dolovich L, et al,. Exploring pharmacists' understanding and adoption of prescribing in 2 Canadian jurisdictions: design and rationale for a mixed-methods approach. Can Pharm J, 2011; 144: 240-244.e1.
11. Makowsky MJ, Guirguis LM, Hughes CA, Sadowski CA, Yuksel N,. Factors influencing pharmacists' adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci, 2013; 8: 109.
12. Hughes CA, Makowsky MJ, Sadowski CA, Schindel T, Yuksel N, Guirguis L,. What prescribing means to pharmacists: a qualitative exploration of practising pharmacists in Alberta. Int J Pharm Pract, Article first published online: 7 NOV 2013 DOI: 10.1111/ijpp.12079.
13. Palys T,. Purposive sampling. In:, Given L, ed. The SAGE encyclopedia of qualitative research methods. Thousand Oaks: Sage Publications, 698-699, 2008.
14. Alberta's Primary Care Initiative 2008. Available at: http://www.albertapci.ca (accessed 10 September 2008).
15. Silcock J, Raynor DK, Petty D,. The organisation and development of primary care pharmacy in the United Kingdom. Health Policy, 2004; 67: 207-214.
16. Doucette WR, DeSloover Koch Y,. Exploratory study of community pharmacy practice change. J Am Pharm Assoc (Wash), 2000; 40 (May-June): 384-391.
17. Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Aslani P,. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci, 2003; 25: 227-234.
18. Thorne SE,. Interpretive description. Walnut Creek, CA: Left Coast Press, 272, 2008.
19. Alberta College of Pharmacists. 2010-2011 Annual Report. Available at: https://pharmacists.ab.ca/Content-Files/Files/AR2010-11-final.pdf (accessed 11 April 2014).
20. Higby GJ,. The continuing evolution of American pharmacy practice, 1952-2002. J Am Pharm Assoc (Wash), 2002; 42: 12-15.
21. Hepler CD, Strand LM,. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm, 1990; 47: 533-543.
22. Task Force on a Blueprint for Pharmacy. Blueprint for pharmacy: the vision for pharmacy. Ottawa, ON: Canadian Pharmacists Association, 2008.
23. Christensen DB, Farris KB,. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother, 2006; 40: 1400.
24. Noyce PR,. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother, 2007; 41: 861-868.
25. Stewart DC, Maclure K, Bond CM, Cunningham S, Diack L, George J, McCaig DJ,. Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service. Int J Pharm Pract, 2011; 19: 328-332.
26. Dawoud D, Griffiths P, Maben J, Goodyer L, Greene R,. Pharmacist supplementary prescribing: a step toward more independence? Res Social Adm Pharm, 2011; 7: 246-256.
27. Tully MP, Latif S, Cantrill JA, Parker D,. Pharmacists' changing views of their supplementary prescribing authority. Pharm World Sci, 2007; 29: 628-634.
28. Clause S, Fudin J, Mergner A, Lutz JL, Chirumamilla S,. Prescribing privileges among pharmacists in Veterans Affairs medical centers. Am J Health Syst Pharm, 2001; 58: 1143-1145.
29. George J, McCaig D, Bond CM, Cunningham IT, Stewart DC,. Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers. Int J Pharm Pract, 2007; 15: 23-30.
30. Hutchison M, Lindblad A, Guirguis L, Cooney D, Rodway M,. Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization. Am J Health Syst Pharm, 2012; 69: 1983-1992.
31. Task Force on Pharmacist Prescribing. Statement on pharmacist prescribing. Can J Hosp Pharm, 2002; 55: 55.
32. Pharmacist Prescribing Task Force. Prescribing by pharmacists: information paper. Can J Hosp Pharm, 2010; 63: 267-274.
33. Hobson RJ, Sewell GJ,. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci, 2006; 28: 76-90.
34. George J, McCaig DJ, Bond CM, Cunningham IT, Diack HL, Watson AM, Steward DC,. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother, 2006; 40: 1843-1850.
35. Denzin NK, Lincoln YS,. Introduction: the discipline and practice of qualitative research. In:, Denzin NK, Lincoln YS, eds. The Sage handbook of qualitative research, 4th edn. Thousand Oaks: Sage Publications, 1-19, 2011.
36. Seale CF,. Computer-assisted analysis of qualitative interview data. In:, Gubrium JF, Holstein JA, eds. Handbook of interview research: context and method. Thousand Oaks: Sage Publications, 651-670, 2002.